Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cardiol Therapeutics Inc. (CRDL) vs Organigram Global Inc. (OGI)

Cardiol Therapeutics Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. is the larger, with a market value of $202.1M against $155.1M — 1.3× the size. Cardiol Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.4×. Organigram Global Inc. has the higher net margin (28.4% vs 0.00%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 14 metrics below, Organigram Global Inc. leads on 8 and Cardiol Therapeutics Inc. on 6.

Valuation

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
P/E n/m 2.37 20.14
P/S n/m 0.67 2.25
P/B 11.32 0.42 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 16.79 12.29
EV/Sales n/m 0.70 2.56
Earnings yield (14.62%) 42.26% (2.99%)
Free cash flow yield (8.77%) (14.22%) 0.00%

Profitability

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 36.47% 53.94%
Operating margin 0.00% (3.91%) 0.00%
Net margin 0.00% 28.44% 0.00%
Free cash flow margin 0.00% (9.46%) 0.00%
Return on equity (171.13%) 20.20% (0.40%)
Return on assets (124.40%) 12.70% (3.32%)
Return on invested capital 0.00% (1.53%) 0.00%

Growth

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 39.51% 10.01%
EPS growth (last fiscal year) 24.32% 60.00% —
Revenue growth, 5-year CAGR — 24.30% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.04 0.05
Current ratio 5.55 2.61 2.31
Net debt to EBITDA 0.62 (31.56) 0.85

Dividend

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRDL OGI Drug Manufacturers Specialty & Generic median
Market cap 202.10m 155.11m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack